Links

Tools

Export citation

Search in Google Scholar

Efficacy and Safety Results 48 Weeks After Switching From Tenofovir Disoproxil Fumarate (Tdf) to Tenofovir Alafenamide (Taf) vs Continued TDF Treatment in Virologically-Suppressed Patients With Chronic Hepatitis B (Chb)

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown